CLEC12B suppresses lung cancer progression by inducing SHP-1 expression and inactivating the PI3K/AKT signaling pathway
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CLEC12B suppresses lung cancer progression by inducing SHP-1 expression and inactivating the PI3K/AKT signaling pathway
Authors
Keywords
CLEC12B, SHP-1, Lung cancer, Cell behavior, PI3K/AKT
Journal
EXPERIMENTAL CELL RESEARCH
Volume 409, Issue 2, Pages 112914
Publisher
Elsevier BV
Online
2021-11-12
DOI
10.1016/j.yexcr.2021.112914
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Small in Size, but Large in Action: microRNAs as Potential Modulators of PTEN in Breast and Lung Cancers
- (2021) Asal Jalal Abadi et al. Biomolecules
- Therapeutic potential of AMPK signaling targeting in lung cancer: Advances, challenges and future prospects
- (2021) Milad Ashrafizadeh et al. LIFE SCIENCES
- KIR3DL3-HHLA2 is a human immunosuppressive pathway and a therapeutic target
- (2021) Yao Wei et al. Science Immunology
- Inhibition of SHP-1 expands the repertoire of antitumor T cells available to respond to immune checkpoint blockade
- (2020) Jeremy P. Snook et al. Cancer Immunology Research
- Targeted Therapy for Non-Small Cell Lung Cancer
- (2020) Zorawar S. Noor et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Versatile role of curcumin and its derivatives in lung cancer therapy
- (2020) Milad Ashrafizadeh et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Porcine CLEC12B is expressed on alveolar macrophages and blood dendritic cells
- (2020) Elvira Nieto-Pelegrín et al. DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY
- Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8+ T cell exhaustion
- (2020) David H. Peng et al. Nature Communications
- Lung cancer
- (2020) Herb Brody NATURE
- Lung cancer cells and their sensitivity/resistance to cisplatin chemotherapy: Role of microRNAs and upstream mediators
- (2020) Milad Ashrafizadeh et al. CELLULAR SIGNALLING
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The potential role of miR‐29 in health and cancer diagnosis, prognosis, and therapy
- (2019) Mohsen Alizadeh et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Mcl-1 Interacts with Akt to Promote Lung Cancer Progression
- (2019) Guo Chen et al. CANCER RESEARCH
- C‐type lectin receptors of the Dectin‐1 cluster: Physiological roles and involvement in disease
- (2019) Kazuya Tone et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- SHP-1 acts as a Tumor Suppressor in Hepatocarcinogenesis and HCC Progression
- (2018) Liang-Zhi Wen et al. CANCER RESEARCH
- MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance
- (2018) Mohammad Askandar Iqbal et al. MOLECULAR ASPECTS OF MEDICINE
- Inhibition of STAT3 in gastric cancer: role of pantoprazole as SHP-1 inducer
- (2018) Jin Sung Koh et al. Cell and Bioscience
- DCUN1D1 facilitates tumor metastasis by activating FAK signaling and up-regulates PD-L1 in non-small-cell lung cancer
- (2018) Jing Li et al. EXPERIMENTAL CELL RESEARCH
- Pinpointing a potential role for CLEC12B in cancer predisposition through familial exome sequencing
- (2018) Charlotte Derpoorter et al. PEDIATRIC BLOOD & CANCER
- Lung cancer: current therapies and new targeted treatments
- (2017) Fred R Hirsch et al. LANCET
- SHP-1 is a negative regulator of epithelial-mesenchymal transition in hepatocellular carcinoma
- (2017) L-C Fan et al. ONCOGENE
- SHP-1: the next checkpoint target for cancer immunotherapy?
- (2016) H. Angharad Watson et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer
- (2014) Claudia Fumarola et al. BIOCHEMICAL PHARMACOLOGY
- Signal Transducer and Activator of Transcription 3 as Molecular Therapy for Non–Small-Cell Lung Cancer
- (2014) Cheng-Yi Wang et al. Journal of Thoracic Oncology
- Realizing the promise of cancer predisposition genes
- (2014) Nazneen Rahman NATURE
- Differential proteomic analysis of caveolin-1 KO cells reveals Sh2b3 and Clec12b as novel interaction partners of caveolin-1 and Capns1 as a potential mediator of caveolin-1-induced apoptosis
- (2013) Yogesh M. Kulkarni et al. ANALYST
- SHP1-mediated cell cycle redistribution inhibits radiosensitivity of non-small cell lung cancer
- (2013) Rubo Cao et al. Radiation Oncology
- Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
- (2012) Julian R. Molina et al. MAYO CLINIC PROCEEDINGS
- Signaling Networks Associated with AKT Activation in Non-Small Cell Lung Cancer (NSCLC): New Insights on the Role of Phosphatydil-Inositol-3 kinase
- (2012) Marianna Scrima et al. PLoS One
- SHP-1 expression accounts for resistance to imatinib treatment in Philadelphia chromosome-positive cells derived from patients with chronic myeloid leukemia
- (2011) N. Esposito et al. BLOOD
- Src Homology Domain 2-containing Protein-tyrosine Phosphatase-1 (SHP-1) Binds and Dephosphorylates Gα-interacting, Vesicle-associated Protein (GIV)/Girdin and Attenuates the GIV-Phosphatidylinositol 3-Kinase (PI3K)-Akt Signaling Pathway
- (2011) Yash Mittal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Knockdown of protein tyrosine phosphatase SHP-1 inhibits G1/S progression in prostate cancer cells through the regulation of components of the cell-cycle machinery
- (2009) F J Rodríguez-Ubreva et al. ONCOGENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation